Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 181,506 shares at $65.08 ($11.8M) on 2020-06-12, disclosed to the SEC on 2020-06-16.
Open-market sale of $11.8M CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.08 | 88,753 | $5.8M | 48.9% |
| 2 | $65.08 | 88,753 | $5.8M | 48.9% |
| 3 | $65.04 | 2,000 | $130K | 1.1% |
| 4 | $65.04 | 2,000 | $130K | 1.1% |
| Total | $65.08 avg | 181,506 | $11.8M | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |